About 19 results
Open links in new tab
  1. Intratumoral and Systemic Hiltonol® (Poly-ICLC) in Prostate Cancer ...

    Jan 16, 2024 · Summary: This is a partially blinded randomized controlled phase II pilot study comparing Poly-ICLC (Hiltonol®) treatment vs no treatment, for prostate cancer participants on active …

  2. Turning 18 Months into 18 Years | Mount Sinai - New York

    When Bill was first informed of his advanced disease (Gleason Total Score 9, Grade T-3A) in 1995, the recommendation to go on hormone therapy with Lupron. In addition, Bill made dramatic lifestyle …

  3. Healthcare & Patient Services | Mount Sinai - New York

    Mount Sinai Health System offers patients the full range of clinical care specialties and treatments, as well as a vast network of facilities.

  4. Active Surveillance | Mount Sinai - New York

    Active surveillance is most appropriate for you medically if: You aren’t experiencing any symptoms You have a slow-growing cancer (Gleason score of less than 6) Your cancer is small (cannot be seen on …

  5. High Intensity Focused Ultrasound (HIFU) - Mount Sinai Health System

    High-Intensity Focused Ultrasound or HIFU is a non-invasive heating procedure for treating localized prostate cancer.

  6. If you have cancer that is clinically insignifi cant (Gleason 6), we would recommend active surveillance. However, if there is clinically signifi cant cancer (any Gleason 7, more than 2 cores of Gleason 6 or …

  7. Subcutaneous Talquetamab in Elderly Patients With Multiple Myeloma …

    Dec 1, 2025 · - With a Gleason score of ≤6, treated within the last 24 months, or untreated and under surveillance - With a Gleason score of 3+4 that has been treated >6 months prior to full study …

  8. Pathology Test Uses Artificial Intelligence to Predict Prostate Cancer ...

    Oct 2, 2018 · A pathology test that applies artificial intelligence (AI) to characterize tissue samples can accurately predict clinically significant prostate cancer disease progression following surgery, …

  9. A Study of BION-1301 in Adults With IgA Nephropathy

    Jul 27, 2023 · Participants with low-risk prostate cancer (i.e., Gleason score < 7 and prostate specific antigen < 10 ng/mL) are allowed. - Pregnancy or breastfeeding or intent to become pregnant or to …

  10. Oncology (Cancer) Health Information | Mount Sinai - New York

    Oncology is the diagnosis and treatment of cancer. Typically, cancer treatment encompasses some combination of surgery, chemotherapy, radiation treatment, and hormone therapy.